EMD Serono, Inc.
9 drugs in NADAC|0 Generic,9 Brand
View Recalls (2)EMD Serono, Inc. lists 9 NDCs in the CMS NADAC file (0 generic, 9 brand), at an average NADAC of $1430.02 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.
Total Drugs
9
0G / 9B
Avg Price / Unit
$1430.0173
$306.06 – $1873.34
Avg 7d Change
-0.02%
Across 1 drugs with changes
7d Activity
of 9 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
FOLLITROPIN market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does EMD Serono, Inc. make?
EMD Serono, Inc. lists 9 NDCs in the CMS NADAC file — 0 generic and 9 brand products.
What is the average price of EMD Serono, Inc. drugs?
The average NADAC across EMD Serono, Inc.'s portfolio is $1430.0173 per unit, ranging from $306.0574 to $1873.3445.
What types of drugs does EMD Serono, Inc. make?
EMD Serono, Inc. makes drugs across 2 FDA pharmacologic classes. The most common by NDC count are Gonadotropin (4), Interferon beta (3).
Has EMD Serono, Inc. had any drug recalls?
2 FDA recalls are matched to EMD Serono, Inc. in the openFDA feed, most recently on Jun 29, 2020.
How has EMD Serono, Inc.'s pricing changed recently?
Over the past 7 days, 0 EMD Serono, Inc. products rose and 1 fell, with a portfolio-wide average change of -0.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
GONAL-F RFF REDI-JECT 900 UNIT PEN FOLLITROPIN | $1873.3445 per ML | — |
GONAL-F RFF REDI-JECT 300 UNITS PEN FOLLITROPIN | $1866.5467 per ML | — |
REBIF 44 MCG/0.5 ML SYRINGE interferon beta-1a | $1849.8837 per ML | — |
REBIF REBIDOSE 44 MCG/0.5 ML INTERFERON BETA-1A | $1848.6728 per ML | — |
GONAL-F RFF REDI-JECT 450 UNIT PEN FOLLITROPIN | $1846.9120 per ML | — |
REBIF 22 MCG/0.5 ML SYRINGE INTERFERON BETA-1A | $1400.9343 per ML | — |
GONAL-F 450 UNITS VIAL follitropin alfa | $1392.3720 per EA | — |
OVIDREL 250 MCG/0.5 ML SYRG choriogonadotropin alfa | $485.4320 per ML | -0.02% |
CETROTIDE 0.25 MG VIAL cetrorelix acetate | $306.0574 per EA | — |
FDA Recalls (2)
Recalls matched by company name. Verify current status with FDA.
Cetrotide (cetrorelix acetate for Injection) 0.25 mg, Sterile - for subcutaneous use only, Rx Only, Manufactured for: EMD Serono, Inc., Rockland, MD 02370, NDC: 44087-1225-1
Defective Container: Market complaints of missing rubber stoppers from drug vial. Missing rubber stoppers could lead to lack of sterility assurance.
ClomiPHENE CITRATE Tablets, USP, 50 mg, 10-count (2 foil sealed plastic trays of 5 tablets each) per carton, Rx only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD., Jerusalem, 91010, Israel; Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; NDC 0093-0041-03, UPC 3 0093-0041-03 7.
Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.